| Event chart LIPOCINE INC. |
|
|
|
| Upcoming events on LIPOCINE INC. |
|
| 06/08/22 | 12:00pm | | Annual General Meeting |
| 08/10/22 | | Interim 2022 Earnings Release (Projected) |
| 11/09/22 | | Q3 2022 Earnings Release (Projected) |
| 03/08/23 | | FY 2022 Earnings Release (Projected) |
| 05/08/23 | | Q1 2023 Earnings Release (Projected) |
|
| Past events on LIPOCINE INC. |
|
| 05/09/22 | 08:00am | | Q1 2022 Earnings Release |
| 03/09/22 | 08:00am | | FY 2021 Earnings Release |
| 01/07/22 | 12:15pm | | NASH-TAG Conference - Podium |
| 01/06/22 | | Nash-tag conference - abstract number: 9 |
| 01/06/22 | | Nash-tag conference - abstract number: 0 |
| 01/06/22 | | Nash-tag conference - abstract number: 1 |
| 01/05/22 | | LifeSci Partners Corporate Access Event |
| 11/12/21 | | American association for the study of liver diseases meeting - abstract number: lp46 |
| 11/12/21 | | American association for the study of liver diseases meeting - abstract number: lp47 |
| 11/12/21 | | American association for the study of liver diseases meeting - abstract number: 1876 |
|
| Past dividends on LIPOCINE INC. |
|
- No events available -
|
|
|
| Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales
M $ |
Released
Forecast
Spread |
| 0,43
0,42
2,2% | 0,16
0,20
-18% |
| 16,1
3,75
330% |
2,21
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -21,2
-21,0
-1,2% | -11,3
-11,2
-1,5% | -12,9
-12,5
-3,2% | -18,0
-17,1
-5,1% | 3,15
-10,5
130% |
-12,2
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -21,0
-20,8
-0,87% | -11,7
-11,5
-1,3% | -13,0
-12,8
-1,6% | -21,0
-20,4
-2,6% | -0,63
-13,0
95% |
-12,7
|
Net income
M $ |
Released
Forecast
Spread | -21,0
-20,8
-0,87% | -11,7
-11,5
-1,3% | -13,0
-12,8
-1,6% | -21,0
-20,4
-2,6% | -0,63
-13,0
95% |
-12,7
|
EPS
$ |
Released
Forecast
Spread | -1,05
-1,03
-2,2% | -0,55
-0,53
-3,8% | -0,50
-0,50
0,00% | -0,38
-0,37
-2,7% | -0,01
-0,15
93% |
-0,14
| | Announcement Date | 03/12/2018 | 03/06/2019 | 03/13/2020 | 03/11/2021 | 03/09/2022 | - |
|
|
|
| Fiscal Period : December | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
Sales
M $ |
Released
Forecast
Spread |
|
|
|
|
|
| 0,05
| 16,1
3,67
339% |
2,00
|
0,26
|
0,80
|
1,15
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread |
| -4,22
-3,43
-23% | -4,38
-3,98
-9,9% | -4,80
-3,93
-22% | -3,11
-4,85
36% | -2,99
-4,15
28% | -3,53
-3,90
9,3% | 12,8
-0,84
1 619% | -3,13
-1,52
-106% |
-3,37
|
-2,77
|
-2,94
|
|
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread |
| -6,37
-4,03
-58% | -4,31
-4,03
-7,0% | -4,51
-3,97
-14% | -3,37
-4,80
30% | -6,81
-4,20
-62% | -3,08
-3,94
22% | 12,6
-0,89
1 516% | -3,49
-1,50
-133% |
-3,38
|
-2,79
|
-2,99
|
|
|
Net income
M $ |
Released
Forecast
Spread |
| -6,37
-4,03
-58% | -4,31
-4,03
-7,0% | -4,51
-3,97
-14% | -3,37
-4,80
30% | -6,81
-4,20
-62% | -3,08
-3,94
22% | 12,6
-0,89
1 516% | -3,49
-1,50
-133% |
-3,38
|
-2,79
|
-2,99
|
|
|
EPS
$ |
Released
Forecast
Spread | -0,14
-0,08
-75% | -0,13
-0,07
-86% | -0,07
-0,06
-17% | -0,06
-0,06
5,3% | -0,04
-0,05
20% | -0,08
-0,05
-60% | -0,03
-0,04
29% | 0,14
-0,01
1 500% | -0,04
-0,02
-100% |
-0,04
|
-0,03
|
-0,04
|
-0,03
|
-0,02
| | Announcement Date | 05/07/2020 | 08/06/2020 | 11/10/2020 | 03/11/2021 | 05/06/2021 | 08/05/2021 | 11/10/2021 | 03/09/2022 | 05/09/2022 | - | - | - | - | - | |
|
|
| Upcoming sector events for LIPOCINE INC. |
|
| |
|
| Past sector events for LIPOCINE INC. |
|
| |
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year